內地餐飲相關股全面造好 美團及九毛九漲9%及14%
今天內地餐飲股回升,九毛九(09922.HK)反覆高見16.32元,現報16元,反彈近14%,成交增至2,720萬股。麥格理將九毛九目標價由39元,大幅下調至23元,同時分別下調公司2021年及2022年盈測12.9%及24.3%,以反映疫情帶來影響,但維持「跑贏大市」評級,相信其表現將繼續優於同行。此外,瑞信也削九毛九目標價至23元,維持「跑贏大市」評級。
美團(03690.HK)五連升兼重越10天及20天線,最高見228.4元,現報226.8元,急升9%。頤海(01579.HK)反覆升5.8%報36.55元。呷哺呷哺(00520.HK)連續第三天穩步回升,最高見5.29元,現報5.15元,升2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.